Dr Buyun Wu, MD, PhD is an expert in Nephrology at Jiangsu Province Hospital (China). Buyun Wu has authored 52 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 218 (community average: 125). How the SLR is computed.

LeadR Profile

Profile validated by the expert
Dr Buyun Wu, MD, PhD Jiangsu Province Hospital China
218 ScienceLeadR Reputation 218
Network Map

Nephrology

Subspecialties: Public Health - Biochemistry - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026
Source: PubMed

Jiangsu Province Hospital - Attending Physician

2017 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 52

Citations

Citations: 337 1st author: 18 Last author: 10 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Drug Rescue for Paxlovid-Induced Tacrolimus Toxicity: A Pooled Analysis of Case Reports.
PMID 42965158 — phenytoin, pharmaceutical preparations, recycling, tacrolimus, therapeutics, rifampin
Kidney Med20260
Acute kidney injury alerts: beyond detection, to effective action.
PMID 42624543 — kidney diseases, kidney, acute kidney injury
Kidney Int20261
Degradation of Sulfadiazine by Biogenic Manganese Oxides Coupled with Syringaldehyde: Performance, Mechanism, Toxicity, and Environmental Applicability.
PMID 42513164 — sulfadiazine, environment
Molecules20260
Pilot Study of Diagnostic Performance of Serum Creatinine/Cystatin C Ratio for Pseudo-AKI.
PMID 42058115 — pilot projects, creatinine, pilots, serum, cystatin c, acute kidney injury, cystatins
Kidney Int Rep20260
Interleukin-17 Inhibitors and the Potential Association of Systemic Lupus Erythematosus.
PMID 42027197 — cohort studies, lupus nephritis, lupus erythematosus, systemic, drug-related side effects and adverse reactions, therapeutics, psoriasis, interleukin-17
Kidney Med20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2

By status:

Completed 1
Enrolling by invitation 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
IVC and Lung Ultrasound B lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure
NCT06373575 — lung, blood, heart failure, heart, blood pressure, prescriptions, physical examination, kidney, vena cava, inferior, critical illness, kidney failure, chronic
N/AEnrolling by invitation2024

LeadR Networks

Main global connection map